Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Khosro Keshavarz
Observed names:
Dr khosro Keshavarz,
K Keshavarz,
K. Keshavarz,
Keshavarz, Khosro,
Kh Keshavarz,
Khosro KESHAVARZ
show all 6
Institutions:
Shiraz University of Medical Sciences,
Bushehr University of Medical Sciences
Observed institutions:
Shiraz University,
Shiraz University of Medical Sciences,
University of Tehran,
Bushehr University of Medical Sciences,
Tehran University of Medical Sciences
ORCID:
0000-0002-5778-5502
Observed ORCID:
0000-0002-5778-5502
OpenAlex ID:
A5071078396
The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran
2021
·
Mohsen Ghaffari Darab
, Khosro Keshavarz
, et al.
·
BMC Health Services Research
·
147
PDF
Economic Burden of Hepatitis B Virus-Related Diseases: Evidence From Iran
2015
·
Khosro Keshavarz
, Abbas Kebriaeezadeh
, et al.
·
Hepatitis Monthly
·
50
PDF
Estimating the Cost of Illness of Prostate Cancer in Iran
2018
·
Mohammad M. Mojahedian
, Mahdi Toroski
, et al.
·
Clinical Therapeutics
·
49
Selective serotonin reuptake inhibitors in major depression disorder treatment: an umbrella review on systematic reviews
2020
·
Mohsen Ghaffari Darab
, Arvin Hedayati
, et al.
·
International Journal of Psychiatry in Clinical Practice
·
36
Economic burden of major depressive disorder: a case study in Southern Iran
2022
·
Khosro Keshavarz
, Arvin Hedayati
, et al.
·
BMC Psychiatry
·
31
PDF
Cost‐Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
2021
·
Ahmad Gholami
, Jassem Azizpoor
, et al.
·
BioMed Research International
·
31
PDF
Effect of two major health reforms on health care cost and utilization in Fars Province of Iran: family physician program and health transformation plan
2020
·
Mohsen Bayati
, Khosro Keshavarz
, et al.
·
BMC Health Services Research
·
30
PDF
Economic burden of breast cancer: a case of Southern Iran
2023
·
Faride Sadat Jalali
, Khosro Keshavarz
, et al.
·
Cost Effectiveness and Resource Allocation
·
25
PDF
Linagliptin versus sitagliptin in patients with type 2 diabetes mellitus: a network meta-analysis of randomized clinical trials
2017
·
Khosro Keshavarz
, Farhad Lotfi
, et al.
·
DARU Journal of Pharmaceutical Sciences
·
18
PDF
Factors Affecting the Utilization of Outpatient Health Services and Importance of Health Insurance
2017
·
Farhad Lotfi
, Soraya Nouraei Motlagh
, et al.
·
Shiraz E-Medical Journal
·
17
PDF
A Cost-Utility and Cost-Effectiveness Analysis of Different Oral Antiviral Medications in Patients With HBeAg-Negative Chronic Hepatitis B in Iran: An Economic Microsimulation Decision Model
2016
·
Khosro Keshavarz
, Abbas Kebriaeezadeh
, et al.
·
Hepatitis Monthly
·
17
PDF
Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?
2012
·
Khosro Keshavarz
, Abbas Kebriaeezadeh
, et al.
·
DARU Journal of Pharmaceutical Sciences
·
17
Positron Emission Mammography (PEM) in the diagnosis of breast cancer: A systematic review and economic evaluation
2020
·
Khosro Keshavarz
, Mojtaba Jafari
, et al.
·
Medical Journal of the Islamic Republic of Iran
·
16
PDF
A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection
2016
·
Seyed Moayed Alavian
, Shekoufeh Nikfar
, et al.
·
Iranian Red Crescent Medical Journal
·
16
PDF
Is Taurolidine-citrate an effective and cost-effective hemodialysis catheter lock solution? A systematic review and cost- effectiveness analysis.
2016
·
Zahra Kavosi
, Maryam Sarikhani Khorrami
, et al.
·
PubMed Central
·
16
PDF
Economic Burden of Scorpion Sting and Snake Bite from a Social Perspective in Iran
2017
·
Iman Mashhadi
, Zahra Kavousi
, et al.
·
Shiraz E-Medical Journal
·
15
PDF
Cost-effectiveness of rabies post exposure prophylaxis in Iran.
2014
·
Nahid Hatam
, Firooz Esmaelzade
, et al.
·
PubMed
·
15
Pharmacists remuneration models in iran and selected countries: a comparative study.
2013
·
Amir Hashemi-Meshkini
, Khosro Keshavarz
, et al.
·
PubMed Central
·
15
PDF
Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis
2022
·
Mehdi Rezaee
, Mohammad Hossein Morowvat
, et al.
·
BMC Health Services Research
·
14
PDF
Fingolimod versus natalizumab in patients with relapsing remitting multiple sclerosis: a cost-effectiveness and cost-utility study in Iran
2018
·
Mehdi Rezaee
, Sadegh Izadi
, et al.
·
Journal of Medical Economics
·
14
PDF
COVID-19 Reinfection Rate and Related Risk Factors in Fars Province, Iran: A Retrospective Cohort Study.
2023
·
Ali Tavakoli
, Farhad Lotfi
, et al.
·
PubMed Central
·
13
PDF
Lessons from one year experience of pooled procurement of pharmaceuticals: exploration of indicators and assessing pharmacies` performance
2018
·
Peivand Bastani
, Mohammad Hadi Imanieh
, et al.
·
DARU Journal of Pharmaceutical Sciences
·
12
PDF
Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
2013
·
Amir Hashemi-Meshkini
, Khosro Keshavarz
, et al.
·
Archives of Medical Science
·
12
PDF
Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma: a systematic review and meta-analysis
2023
·
Zahra Goudarzi
, Mehrdad Mostafavi
, et al.
·
Cost Effectiveness and Resource Allocation
·
11
PDF
Deductibles in Health Insurance, Beneficial or Detrimental: A Review Article
2020
·
Iman MIRIAN
, Mohammad Javad KABIR
, et al.
·
Iranian Journal of Public Health
·
11
Show more works
View as search
Works count:
112
Citation count:
904
H-index:
15
I10-index:
29
Year
Topic
Type